Augmented anti-cancer effect of hypoxia-inducible factor 2α (HIF2α)- targeting PT2385 delivered in α-synuclein-AuNP microcapsules for clear cell renal carcinoma mouse model

Eun Jeong Nam, Su Kang Kong, Inyoung Cho, Seung R. Paik, Young Sik Kim

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Development of anti-cancer drug carrier system capable of delivering chemotherapeutic and immunotherapeutic agents to cancerous lesions is essential to overcome severe side effects and reduced therapeutic efficacy of the drugs. The microcapsules of gold nanoparticles (AuNPs) fabricated with a self-assembly protein of alpha-synuclein (αS) have been employed to carry the hypoxia-inducible factor 2α (HIF2α)-targeting PT2385 in a mouse model xenografted with clear cell renal cell carcinoma (ccRCC). Hydrophobic cargo like rhodamine 6G entrapped within the microcapsules was demonstrated to be selectively released under cancer-related stimuli including acidic pH, local hyperthermia, and proteases such as matrix metalloproteinases. The αS-AuNP microcapsules containing the hydrophobic drug of PT2385 suppressed the expression of HIF2α and its downstream genes in ccRCC A498 cells in vitro to the level comparable to that obtained with direct PT2385 treatment, indicating that the PT2385 remained active inside the capsules. In the A498 xenograft mouse model, intraperitoneal administration of the αS-AuNP-PT2385 microcapsules significantly reduced the tumor volume and Ki-67 scores from those monitored in the PT2385-treated group. Therefore, the αS-AuNP microcapsule is suggested to be a promising cancer-targeting drug delivery system which exhibits several merits such as improved loading efficiency for hydrophobic drugs, their protection from metabolism, and selective cargo release in tumor microenvironments in addition to its physicotherapeutic potential due to the photothermal effect of AuNPs.

Original languageEnglish
Article number105179
JournalJournal of Drug Delivery Science and Technology
Volume91
DOIs
Publication statusPublished - 2024 Jan

Bibliographical note

Publisher Copyright:
© 2023 Elsevier B.V.

Keywords

  • Cancer-targeting drug delivery system
  • Clear cell renal cell carcinoma xenograft model
  • Gold nanoparticle-assembled microcapsules
  • PT2385
  • Tumor microenvironment

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Augmented anti-cancer effect of hypoxia-inducible factor 2α (HIF2α)- targeting PT2385 delivered in α-synuclein-AuNP microcapsules for clear cell renal carcinoma mouse model'. Together they form a unique fingerprint.

Cite this